Scotia Capital Inc. Pro Mis Neurosciences Inc. Transaction History
Scotia Capital Inc.
- $22.1 Billion
- Q3 2025
A detailed history of Scotia Capital Inc. transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Scotia Capital Inc. holds 12,122 shares of PMN stock, worth $4,727. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,122
Previous 12,122
-0.0%
Holding current value
$4,727
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PMN
# of Institutions
25Shares Held
10MCall Options Held
0Put Options Held
0-
Ally Bridge Group (Ny) LLC New York, NY6.23MShares$2.43 Million2.7% of portfolio
-
Armistice Capital, LLC New York, NY2.97MShares$1.16 Million0.02% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3295KShares$115,1220.03% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il170KShares$66,3300.0% of portfolio
-
Hrt Financial LP New York, NY68.1KShares$26,5420.0% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...